这是一篇来自已证抗体库的有关人类 KRT17的综述，是根据71篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合KRT17 抗体。
KRT17 同义词: 39.1; CK-17; K17; PC; PC2; PCHC1

赛默飞世尔
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100; 图 6b
赛默飞世尔 KRT17抗体（eBioscience, 53-9003-82)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 6b). Commun Biol (2022) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 2, 4a, 4b
赛默飞世尔 KRT17抗体（InVitrogen, MA5-13156)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:1000 (图 2, 4a, 4b). Mol Oncol (2022) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:500; 图 2b
赛默飞世尔 KRT17抗体（Lab Vision, MS-343-P)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:500 (图 2b). Sci Adv (2021) ncbi
小鼠 单克隆（AE1/AE3）
  • 流式细胞仪; 人类
赛默飞世尔 KRT17抗体（eBioscience, 53-9003-82)被用于被用于流式细胞仪在人类样本上. Nat Commun (2021) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 图 4a
赛默飞世尔 KRT17抗体（eBioscience, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 4a). Proc Natl Acad Sci U S A (2020) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 猕猴; 0.2 ug/ml; 图 4g
赛默飞世尔 KRT17抗体（Thermo Fisher, 41-9003-82)被用于被用于免疫组化-石蜡切片在猕猴样本上浓度为0.2 ug/ml (图 4g). Science (2020) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:500; 图 1a
赛默飞世尔 KRT17抗体（eBioscience, 53-9003-80)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:500 (图 1a). Nat Cell Biol (2020) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类; 图 4, 5
赛默飞世尔 KRT17抗体（eBioscience, AE1/AE3)被用于被用于免疫细胞化学在人类样本上 (图 4, 5). Breast Cancer Res (2019) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫细胞化学; 人类; 图 s1b
赛默飞世尔 KRT17抗体（Thermo Fischer, MA5-13203)被用于被用于免疫细胞化学在人类样本上 (图 s1b). Sci Rep (2017) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:150; 表 2
赛默飞世尔 KRT17抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (表 2). Hum Pathol (2017) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 图 3d
赛默飞世尔 KRT17抗体（Thermo Scientific, AE1-AE3)被用于被用于免疫组化在人类样本上 (图 3d). Case Rep Pathol (2016) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫细胞化学; 小鼠; 图 3c
  • 免疫印迹; 小鼠; 图 3d
赛默飞世尔 KRT17抗体（Thermo Scientific, MA5-13203)被用于被用于免疫细胞化学在小鼠样本上 (图 3c) 和 被用于免疫印迹在小鼠样本上 (图 3d). Oncogene (2017) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 图 5b
赛默飞世尔 KRT17抗体（Thermo Scientific, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上 (图 5b). Breast Cancer Res Treat (2016) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类; 1:50; 图 1
赛默飞世尔 KRT17抗体（ThermoFisher Scientific, MA5-13156)被用于被用于免疫细胞化学在人类样本上浓度为1:50 (图 1). Future Oncol (2016) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 图 s3
赛默飞世尔 KRT17抗体（分子探针, 985542A)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s3). Microbiome (2015) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫组化-石蜡切片; 小鼠; 图 4
赛默飞世尔 KRT17抗体（Thermo Scientific, MA5-13203)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 4). Sci Rep (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:50; 图 3
赛默飞世尔 KRT17抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 3). Pathol Res Pract (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 小鼠; 1:100; 表 2
赛默飞世尔 KRT17抗体（eBioscience, 41-9003)被用于被用于免疫细胞化学在小鼠样本上浓度为1:100 (表 2). J Cell Physiol (2016) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 表 2
赛默飞世尔 KRT17抗体（Thermo Scientific, AE1/AE3)被用于被用于免疫组化在人类样本上 (表 2). Diagn Cytopathol (2015) ncbi
小鼠 单克隆（E3）
  • 免疫组化; 人类
赛默飞世尔 KRT17抗体（NeoMarkers, E3)被用于被用于免疫组化在人类样本上. Mol Oncol (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 鲤
赛默飞世尔 KRT17抗体（生活技术, MA5-13156)被用于被用于免疫细胞化学在鲤样本上. In Vitro Cell Dev Biol Anim (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 流式细胞仪; 人类
  • 免疫细胞化学; 人类; 1 ul
赛默飞世尔 KRT17抗体（eBioscience, 53-9003-82)被用于被用于流式细胞仪在人类样本上 和 被用于免疫细胞化学在人类样本上浓度为1 ul. Nanomedicine (2015) ncbi
小鼠 单克隆（C11）
  • 免疫印迹; 人类; 1:1000
赛默飞世尔 KRT17抗体（Thermo Scientific, 4545)被用于被用于免疫印迹在人类样本上浓度为1:1000. BMC Cancer (2015) ncbi
小鼠 单克隆（PAN-CK）
  • 免疫印迹; 人类
赛默飞世尔 KRT17抗体（Thermo Fisher Scientific, MA5-13203)被用于被用于免疫印迹在人类样本上. Stem Cell Res Ther (2015) ncbi
小鼠 单克隆（AE1/AE3）
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于. In Vitro Cell Dev Biol Anim (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 10-20 ug/ml
赛默飞世尔 KRT17抗体（Lab.Vision, Ab-1)被用于被用于免疫组化-石蜡切片在人类样本上浓度为10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:100; 图 s6
赛默飞世尔 KRT17抗体（Thermo, MS-34)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:100 (图 s6). Nat Commun (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 5
赛默飞世尔 KRT17抗体（ThermoFisher Scientific, AE1/AE3)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 5). Development (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT17抗体（Neo Markers, MS343)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Comp Med (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3
赛默飞世尔 KRT17抗体（eBioscience, 53-9003-80)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3). Nat Cell Biol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT17抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Hum Pathol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT17抗体（Thermo Fisher Scientific, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Rom J Morphol Embryol (2014) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于被用于免疫细胞化学在人类样本上. Histopathology (2015) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类
赛默飞世尔 KRT17抗体（Thermo, AE1/AE3)被用于被用于免疫组化在人类样本上. BMC Med Imaging (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类
赛默飞世尔 KRT17抗体（Thermo Fisher, AE1/AE3)被用于被用于免疫细胞化学在人类样本上. Biomed Mater (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类
赛默飞世尔 KRT17抗体（Thermoelectron, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上. BMC Med Imaging (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100; 表 2
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (表 2). Sci Rep (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 人类; 1:100; 图 1
赛默飞世尔 KRT17抗体（eBioscience, AE1/AE3)被用于被用于免疫细胞化学在人类样本上浓度为1:100 (图 1). PLoS ONE (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 表 1
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化在人类样本上 (表 1). Head Face Med (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 1:200; 图 4
赛默飞世尔 KRT17抗体（Zymed, AE1-AE3)被用于被用于免疫组化在人类样本上浓度为1:200 (图 4). Surg Neurol Int (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化; 人类; 图 2
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化在人类样本上 (图 2). Diagn Pathol (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫细胞化学; 大西洋鲑鱼; 1:50; 图 2
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于被用于免疫细胞化学在大西洋鲑鱼样本上浓度为1:50 (图 2). Virol J (2013) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:100
赛默飞世尔 KRT17抗体（Invitrogen, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100. Med Sci Monit (2012) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 小鼠
赛默飞世尔 KRT17抗体（Thermo Scientific, MS-343)被用于被用于免疫组化-石蜡切片在小鼠样本上. Anat Cell Biol (2011) ncbi
小鼠 单克隆（C-11）
  • 免疫组化-石蜡切片; 人类; 1:100
  • 免疫细胞化学; 人类; 1:100
赛默飞世尔 KRT17抗体（Labvision, MS-149)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 和 被用于免疫细胞化学在人类样本上浓度为1:100. Br J Cancer (2012) ncbi
小鼠 单克隆（C11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT17抗体（Invitrogen, C-11)被用于被用于免疫印迹在小鼠样本上. Infect Immun (2009) ncbi
小鼠 单克隆（C-11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT17抗体（Invitrogen, C-11)被用于被用于免疫印迹在小鼠样本上. Infect Immun (2009) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:200
赛默飞世尔 KRT17抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200. Cancer (2008) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫印迹; 人类; 图 5
赛默飞世尔 KRT17抗体（Lab Vision, MS-343-P)被用于被用于免疫印迹在人类样本上 (图 5). Int J Cancer (2005) ncbi
小鼠 单克隆（C11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT17抗体（NeoMarkers, C-11)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2004) ncbi
小鼠 单克隆（C-11）
  • 免疫印迹; 小鼠
赛默飞世尔 KRT17抗体（NeoMarkers, C-11)被用于被用于免疫印迹在小鼠样本上. Mol Cell Biol (2004) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫组化-石蜡切片; 人类; 1:80; 表 1
赛默飞世尔 KRT17抗体（Zymed, AE1/AE3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:80 (表 1). Pathol Int (2004) ncbi
小鼠 单克隆（AE1/AE3）
  • 免疫印迹; 人类; 1:1000; 图 2
赛默飞世尔 KRT17抗体（Zymed, AE1/AE3)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2). Gynecol Oncol (2003) ncbi
艾博抗（上海）贸易有限公司
domestic rabbit 单克隆（EPR1624Y）
  • 免疫印迹; 人类; 1:100; 图 3c
艾博抗（上海）贸易有限公司 KRT17抗体（abcam, ab51056)被用于被用于免疫印迹在人类样本上浓度为1:100 (图 3c). Am J Cancer Res (2022) ncbi
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 小鼠; 1:400; 图 4d
  • 免疫印迹; 小鼠; 1:1000; 图 4j
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, ab53707)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:400 (图 4d) 和 被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4j). Br J Pharmacol (2021) ncbi
domestic rabbit 单克隆
  • 免疫组化; 人类; 1:50; 图 1e
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, AB183330)被用于被用于免疫组化在人类样本上浓度为1:50 (图 1e). JCI Insight (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:1000; 图 5c
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, ab53707)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5c). Cell Prolif (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:1000; 图 s2i
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, Ab53707)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 s2i). Nat Commun (2020) ncbi
domestic rabbit 单克隆（EP1623）
  • 免疫组化-石蜡切片; 小鼠; 图 7a
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, ab109725)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 7a). Redox Biol (2020) ncbi
domestic rabbit 单克隆（EP1623）
  • 免疫组化-冰冻切片; 小鼠; 1:3000; 图 1b
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, 109725)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:3000 (图 1b). elife (2019) ncbi
domestic rabbit 单克隆（EPR1624Y）
  • 免疫印迹基因敲除验证; 人类; 图 2
  • 免疫细胞化学; 人类; 图 2
  • 免疫组化; 人类; 图 1
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, EPR1624Y)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 2), 被用于免疫细胞化学在人类样本上 (图 2) 和 被用于免疫组化在人类样本上 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 单克隆（EPR1624Y）
  • 免疫印迹; 人类; 图 7
艾博抗（上海）贸易有限公司 KRT17抗体（abcam, ab51056)被用于被用于免疫印迹在人类样本上 (图 7). Oncotarget (2016) ncbi
domestic rabbit 多克隆
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, ab53707)被用于. J Cell Biol (2015) ncbi
domestic rabbit 单克隆（EP1623）
  • 免疫细胞化学; 人类; 1:100
艾博抗（上海）贸易有限公司 KRT17抗体（Abcam, ab109725)被用于被用于免疫细胞化学在人类样本上浓度为1:100. Regen Med (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆（C46）
  • 免疫组化-石蜡切片; 小鼠; 1:200; 图 1
圣克鲁斯生物技术 KRT17抗体（Santa Cruz, sc-8421)被用于被用于免疫组化-石蜡切片在小鼠样本上浓度为1:200 (图 1). Mol Endocrinol (2016) ncbi
小鼠 单克隆（E3）
  • 免疫细胞化学; 人类; 图 1
圣克鲁斯生物技术 KRT17抗体（santa Cruz, sc-58726)被用于被用于免疫细胞化学在人类样本上 (图 1). Mol Vis (2015) ncbi
小鼠 单克隆（E3）
  • 免疫组化-冰冻切片; 人类
圣克鲁斯生物技术 KRT17抗体（Santa Cruz biotechnology, sc-58726)被用于被用于免疫组化-冰冻切片在人类样本上. Exp Eye Res (2014) ncbi
赛信通（上海）生物试剂有限公司
domestic rabbit 单克隆（D12E5）
  • 免疫印迹; 人类; 图 5b
赛信通（上海）生物试剂有限公司 KRT17抗体（Cell Signaling, 12509)被用于被用于免疫印迹在人类样本上 (图 5b). J Proteome Res (2017) ncbi
domestic rabbit 单克隆（D73C7）
  • 免疫印迹基因敲除验证; 人类; 图 2
  • 免疫细胞化学; 人类; 图 2
  • 免疫组化; 人类; 图 1
赛信通（上海）生物试剂有限公司 KRT17抗体（Cell Signaling, D7327)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 2), 被用于免疫细胞化学在人类样本上 (图 2) 和 被用于免疫组化在人类样本上 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 单克隆（D12E5）
  • 免疫组化; 人类; 图 s3
赛信通（上海）生物试剂有限公司 KRT17抗体（Cell Signaling, 12509)被用于被用于免疫组化在人类样本上 (图 s3). Oncotarget (2016) ncbi
domestic rabbit 单克隆（D12E5）
  • 免疫细胞化学; 人类; 图 3f
  • 免疫印迹; 人类; 图 3h
赛信通（上海）生物试剂有限公司 KRT17抗体（Cell Signaling, D12E5)被用于被用于免疫细胞化学在人类样本上 (图 3f) 和 被用于免疫印迹在人类样本上 (图 3h). Sci Rep (2016) ncbi
丹科医疗器械技术服务（上海）有限公司
小鼠 单克隆（E3）
  • 免疫组化-石蜡切片; 人类; 1:100; 图 1e
丹科医疗器械技术服务（上海）有限公司 KRT17抗体（Dako, E3)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 1e). Hum Pathol (2016) ncbi
小鼠 单克隆（E3）
  • 免疫组化; 人类; 1:200; 图 e5
丹科医疗器械技术服务（上海）有限公司 KRT17抗体（Dako, M7046)被用于被用于免疫组化在人类样本上浓度为1:200 (图 e5). Nature (2016) ncbi
徕卡显微系统(上海)贸易有限公司
单克隆（E3）
  • 免疫组化; 人类; 图 9a
徕卡显微系统(上海)贸易有限公司 KRT17抗体（Leica Biosystems, PA0117)被用于被用于免疫组化在人类样本上 (图 9a). J Clin Invest (2017) ncbi
文章列表
  1. Castillo P, Aisagbonhi O, Saenz C, ElShamy W. Novel insights linking BRCA1-IRIS role in mammary gland development to formation of aggressive PABCs: the case for longer breastfeeding. Am J Cancer Res. 2022;12:396-426 pubmed
  2. Rodriguez E, Boelaars K, Brown K, Madunić K, van Ee T, Dijk F, et al. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits. Commun Biol. 2022;5:41 pubmed 出版商
  3. Bruun J, Eide P, Bergsland C, Brück O, Svindland A, Arjama M, et al. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol. 2022;16:2312-2329 pubmed 出版商
  4. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed 出版商
  5. Ryu Y, Lee D, Shim J, Park J, Kim Y, Choi S, et al. KY19382, a novel activator of Wnt/β-catenin signalling, promotes hair regrowth and hair follicle neogenesis. Br J Pharmacol. 2021;178:2533-2546 pubmed 出版商
  6. DePianto D, Heiden J, Morshead K, Sun K, Modrusan Z, Teng G, et al. Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population. JCI Insight. 2021;6: pubmed 出版商
  7. Rodriguez E, Boelaars K, Brown K, Eveline Li R, Kruijssen L, Bruijns S, et al. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nat Commun. 2021;12:1270 pubmed 出版商
  8. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed 出版商
  9. Huang W, Yu D, Wang M, Han Y, Lin J, Wei D, et al. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Cell Prolif. 2020;53:e12836 pubmed 出版商
  10. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed 出版商
  11. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed 出版商
  12. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed 出版商
  13. Casares L, Garcia V, Garrido Rodríguez M, Millán E, Collado J, Garcia Martin A, et al. Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020;28:101321 pubmed 出版商
  14. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed 出版商
  15. Jenkins B, Fontecilla N, Lu C, Fuchs E, Lumpkin E. The cellular basis of mechanosensory Merkel-cell innervation during development. elife. 2019;8: pubmed 出版商
  16. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed 出版商
  17. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed 出版商
  18. Adams C, Kim A, Mitra R, Choi J, Gong J, Eischen C. BCL-W has a fundamental role in B cell survival and lymphomagenesis. J Clin Invest. 2017;127:635-650 pubmed 出版商
  19. Foster M, Gwinn W, Kelly F, Brass D, Valente A, Moseley M, et al. Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. J Proteome Res. 2017;16:538-549 pubmed 出版商
  20. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  21. Khanom R, Nguyen C, Kayamori K, Zhao X, Morita K, Miki Y, et al. Keratin 17 Is Induced in Oral Cancer and Facilitates Tumor Growth. PLoS ONE. 2016;11:e0161163 pubmed 出版商
  22. Babkair H, Yamazaki M, Uddin M, Maruyama S, Abe T, Essa A, et al. Aberrant expression of the tight junction molecules claudin-1 and zonula occludens-1 mediates cell growth and invasion in oral squamous cell carcinoma. Hum Pathol. 2016;57:51-60 pubmed 出版商
  23. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed 出版商
  24. Hatem R, El Botty R, Chateau Joubert S, Servely J, Labiod D, de Plater L, et al. Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers. Oncotarget. 2016;7:48206-48219 pubmed 出版商
  25. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed 出版商
  26. Kuga T, Sasaki M, Mikami T, Miake Y, Adachi J, Shimizu M, et al. FAM83H and casein kinase I regulate the organization of the keratin cytoskeleton and formation of desmosomes. Sci Rep. 2016;6:26557 pubmed 出版商
  27. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed 出版商
  28. Terakawa J, Rocchi A, Serna V, Bottinger E, Graff J, Kurita T. FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian Duct. Mol Endocrinol. 2016;30:783-95 pubmed 出版商
  29. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed 出版商
  30. Kramerov A, Saghizadeh M, Maguen E, Rabinowitz Y, Ljubimov A. Persistence of reduced expression of putative stem cell markers and slow wound healing in cultured diabetic limbal epithelial cells. Mol Vis. 2015;21:1357-67 pubmed
  31. Shu S, Lin C, He H, Witwicki R, Tabassum D, Roberts J, et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature. 2016;529:413-417 pubmed 出版商
  32. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed 出版商
  33. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed 出版商
  34. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed 出版商
  35. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed 出版商
  36. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed 出版商
  37. Gromova I, Gromov P, Honma N, Kumar S, Rimm D, Talman M, et al. High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy. Mol Oncol. 2015;9:1636-54 pubmed 出版商
  38. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed 出版商
  39. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed 出版商
  40. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed 出版商
  41. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed 出版商
  42. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed 出版商
  43. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  44. Wright M, Reed Geaghan E, Bolock A, Fujiyama T, Hoshino M, Maricich S. Unipotent, Atoh1+ progenitors maintain the Merkel cell population in embryonic and adult mice. J Cell Biol. 2015;208:367-79 pubmed 出版商
  45. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed 出版商
  46. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed 出版商
  47. Saghizadeh M, Dib C, Brunken W, Ljubimov A. Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells. Exp Eye Res. 2014;129:66-73 pubmed 出版商
  48. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  49. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed 出版商
  50. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed 出版商
  51. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  52. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed 出版商
  53. Sternberg H, Jiang J, Sim P, Kidd J, Janus J, Rinon A, et al. Human embryonic stem cell-derived neural crest cells capable of expressing markers of osteochondral or meningeal-choroid plexus differentiation. Regen Med. 2014;9:53-66 pubmed 出版商
  54. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed 出版商
  55. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed 出版商
  56. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed 出版商
  57. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed 出版商
  58. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed 出版商
  59. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed 出版商
  60. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed 出版商
  61. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed 出版商
  62. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed 出版商
  63. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  64. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed 出版商
  65. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed 出版商
  66. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed 出版商
  67. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed 出版商
  68. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  69. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  70. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  71. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed